ProForma 2.0
validated simple linear
HSDAVFTDNYTRLRKQMAVKKYLNSILN
Record tools
Copy identifiers or export this single peptide record for a local research note.
Vasoactive intestinal peptide, VIP
85
Quality PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness.
9
Source DBs
65
Activities
44
Source refs
11
Literature
0
Patents
Integrated record
Length
Molecular weight
Formula
Structure type
Synthesis
Chirality
Family
Gene
Residue composition
Physicochemical profile
Membrane affinity proxy
Solubility proxy
Net charge proxy +4
Binding interaction proxy
Versioned scientific descriptors
Legacy compatibility fields are materialized from the versioned PepDiana computed release; no separate source-reported property is available.
Molecular weight
3326.7815 Da
Molecular formula
C147H237N43O43S
Theoretical pI
9.8209
Net charge at pH 7
2.8445
GRAVY
-0.6393
Instability index
32.1893
Aromaticity
0.1071
Topological polar surface area
1447.9 Ų
cLogP
-14.6169
Hydrogen-bond donors
51
Hydrogen-bond acceptors
48
Rotatable bonds
113
Method: PepDiana sequence/structure descriptor pipeline
Tool: Biopython+RDKit · Biopython 1.85; RDKit 2024.09.6
Calculated: 2026-06-20T11:01:38.358971+00:00
Assumptions: ph=7; termini=free N-terminus and free C-terminus for simple linear peptides; stereochemistry=standard L-amino acids; smiles_length_limit=200
ProForma 2.0
validated simple linear
HSDAVFTDNYTRLRKQMAVKKYLNSILN
HELM 2.0
validated simple linear
PEPTIDE1{H.S.D.A.V.F.T.D.N.Y.T.R.L.R.K.Q.M.A.V.K.K.Y.L.N.S.I.L.N}$$$$V2.0
Canonical SMILES
validated
CCC(C)C(NC(=O)C(CO)NC(=O)C(CC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(NC(=O)C(C)NC(=O)C(CCSC)NC(=O)C(CCC(N)=O)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CC(N)=O)NC(=O)C(CC(=O)O)NC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(N)Cc1c[nH]cn1)C(C)C)C(C)O)C(C)O)C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(N)=O)C(=O)O
Isomeric SMILES
validated
CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O
Follow-up research
Links open third-party resources with the current PepDiana sequence, record name, or chemistry notation as the initial query.
Research workflow
@misc{PEPDIA-INT-036958,
title = {Vasoactive intestinal peptide, VIP},
author = {{PepDiana Consortium}},
year = {2026},
howpublished = {PepDiana Multifunctional Peptide Database},
url = {http://127.0.0.1:3004/peptides/PEPDIA-INT-036958},
note = {Accessed from local PepDiana development build}
}Vasoactive intestinal peptide, VIP. (2026). PepDiana record PEPDIA-INT-036958. PepDiana Multifunctional Peptide Database. http://127.0.0.1:3004/peptides/PEPDIA-INT-036958
Integrated source-database annotations
| Stable record | Activity | Subtype | Value | Target | Assay method | Source |
|---|---|---|---|---|---|---|
| CTPDB_P036958_ACT_apd_0000 | Antimicrobial | Anti-Gram+ | Not available in the current structured import | Unknown | Not reported by source | AP01477apd / linked |
| CTPDB_P036958_ACT_apd_0001 | Antimicrobial | Antifungal | Not available in the current structured import | Unknown | Not reported by source | AP01477apd / linked |
| CTPDB_P036958_ACT_camp_0003 | Antimicrobial | Antibacterial | Not available in the current structured import | Unknown | Not reported by source | CAMPSQ3268camp / linked |
| CTPDB_P036958_ACT_camp_0004 | Antimicrobial | Anti-Gram+ | Not available in the current structured import | Unknown | Not reported by source | CAMPSQ3268camp / linked |
| CTPDB_P036958_ACT_camp_0005 | Antimicrobial | Anti-Gram- | Not available in the current structured import | Unknown | Not reported by source | CAMPSQ3268camp / linked |
| CTPDB_P036958_ACT_dbaasp_0006 | Antimicrobial | - | 150.7 µg/ml | Streptococcus mutans NCTC 10449 | Not reported by source | DBAASPS_4456_chain0dbaasp / linked |
| CTPDB_P036958_ACT_dbaasp_0007 | Antimicrobial | - | >500 µg/ml | Lactobacillus acidophilus NCTC 1723 | Not reported by source | DBAASPS_4456_chain0dbaasp / linked |
| CTPDB_P036958_ACT_dbaasp_0008 | Antimicrobial | - | 5.2 µg/ml | Escherichia coli ATCC 25922 | Not reported by source | DBAASPS_4456_chain0dbaasp / linked |
| CTPDB_P036958_ACT_dbaasp_0009 | Antimicrobial | - | >500 µg/ml | Enterococcus faecalis NCTC 12697 | Not reported by source | DBAASPS_4456_chain0dbaasp / linked |
| CTPDB_P036958_ACT_dbaasp_0010 | Antimicrobial | - | 4.1 µg/ml | Pseudomonas aeruginosa ATCC 27853 | Not reported by source | DBAASPS_4456_chain0dbaasp / linked |
| CTPDB_P036958_ACT_dbaasp_0011 | Antimicrobial | - | >500 µg/ml | Staphylococcus aureus ATCC 25923 | Not reported by source | DBAASPS_4456_chain0dbaasp / linked |
| CTPDB_P036958_ACT_dbaasp_0012 | Antimicrobial | - | 46.5 µg/ml | Candida albicans NCTC 3179 | Not reported by source | DBAASPS_4456_chain0dbaasp / linked |
| CTPDB_P036958_ACT_dbaasp_0013 | Antimicrobial | - | 17.5 µg/ml | Escherichia coli ATCC 27325 | Not reported by source | DBAASPS_4456_chain0dbaasp / linked |
| CTPDB_P036958_ACT_dbaasp_0014 | Antimicrobial | - | 8.5 µg/ml | Pseudomonas aeruginosa ATCC 15692 | Not reported by source | DBAASPS_4456_chain0dbaasp / linked |
| CTPDB_P036958_ACT_dbaasp_0015 | Antimicrobial | - | 36.87 µg/ml | Streptococcus mutans ATCC 25175 | Not reported by source | DBAASPS_4456_chain0dbaasp / linked |
| CTPDB_P036958_ACT_dbaasp_0016 | Antimicrobial | - | NA | Staphylococcus aureus ATCC 6538P | Not reported by source | DBAASPS_4456_chain0dbaasp / linked |
| CTPDB_P036958_ACT_dbaasp_0017 | Antimicrobial | - | 30 µg/ml | Escherichia coli ATCC 27325 | Not reported by source | DBAASPS_4456_chain0dbaasp / linked |
| CTPDB_P036958_ACT_dbaasp_0018 | Antimicrobial | - | 30 µg/ml | Escherichia coli ATCC 27325 | Not reported by source | DBAASPS_4456_chain0dbaasp / linked |
| CTPDB_P036958_ACT_dbaasp_0019 | Antimicrobial | - | 15 µg/ml | Pseudomonas aeruginosa ATCC 15692 | Not reported by source | DBAASPS_4456_chain0dbaasp / linked |
| CTPDB_P036958_ACT_dbaasp_0020 | Antimicrobial | - | 15 µg/ml | Pseudomonas aeruginosa ATCC 15692 | Not reported by source | DBAASPS_4456_chain0dbaasp / linked |
| CTPDB_P036958_ACT_dbaasp_0021 | Antimicrobial | - | 500 µg/ml | Escherichia coli ATCC 27325 | Not reported by source | DBAASPS_4456_chain0dbaasp / linked |
| CTPDB_P036958_ACT_dbaasp_0022 | Antimicrobial | - | 250 µg/ml | Pseudomonas aeruginosa ATCC 15692 | Not reported by source | DBAASPS_4456_chain0dbaasp / linked |
| CTPDB_P036958_ACT_dramp_0023 | Unknown | Not found | Not available in the current structured import | Unknown | Not reported by source | DRAMP03543dramp / linked |
| CTPDB_P036958_ACT_dramp_0024 | Antimicrobial | Antibacterial | Not available in the current structured import | Unknown | Not reported by source | DRAMP18166dramp / linked |
| CTPDB_P036958_ACT_dramp_0025 | Antimicrobial | - | Not available in the current structured import | Unknown | Not reported by source | DRAMP37193dramp / linked |
| CTPDB_P036958_ACT_dramp_0026 | Antimicrobial | Antibacterial | Not available in the current structured import | Unknown | Not reported by source | DRAMP37193dramp / linked |
| CTPDB_P036958_ACT_dramp_0027 | Antimicrobial | Anti-Gram+ | Not available in the current structured import | Unknown | Not reported by source | DRAMP37193dramp / linked |
| CTPDB_P036958_ACT_parapep_0028 | Antiparasitic | Antiparasitic | Not available in the current structured import | Unknown | MTT assay | 1321parapep / linked |
| CTPDB_P036958_ACT_parapep_0029 | Antiparasitic | Antiparasitic | 2.8 µM | Unknown | MTT assay | 1322parapep / linked |
| CTPDB_P036958_ACT_peptherdia_0030 | Clinical / Approved Drug | General Therapeutic | Not available in the current structured import | Unknown | Not reported by source | 46peptherdia / linked |
| CTPDB_P036958_ACT_satpdb_0031 | Antimicrobial | Antibacterial | Not available in the current structured import | Unknown | Not reported by source | satpdb20869satpdb / linked |
| CTPDB_P036958_ACT_satpdb_0032 | Antimicrobial | - | Not available in the current structured import | Unknown | Not reported by source | satpdb20869satpdb / linked |
| CTPDB_P036958_ACT_satpdb_0033 | Antimicrobial | Antifungal | Not available in the current structured import | Unknown | Not reported by source | satpdb20869satpdb / linked |
| CTPDB_P036958_ACT_satpdb_0034 | Antimicrobial | Antibacterial | Not available in the current structured import | Unknown | Not reported by source | satpdb25507satpdb / linked |
| CTPDB_P036958_ACT_satpdb_0035 | Antiparasitic | - | Not available in the current structured import | Unknown | Not reported by source | satpdb25507satpdb / linked |
| CTPDB_P036958_ACT_satpdb_0036 | Bioregulatory | Cell-Cell Communication | Not available in the current structured import | Unknown | Not reported by source | satpdb25507satpdb / linked |
| CTPDB_P036958_ACT_satpdb_0037 | Antimicrobial | - | Not available in the current structured import | Unknown | Not reported by source | satpdb25507satpdb / linked |
| CTPDB_P036958_ACT_satpdb_0038 | Antimicrobial | Antifungal | Not available in the current structured import | Unknown | Not reported by source | satpdb25507satpdb / linked |
| CTPDB_P036958_ACT_satpdb_0039 | Cell-Penetrating | Drug Delivery | Not available in the current structured import | Unknown | Not reported by source | satpdb25507satpdb / linked |
| CTPDB_P036958_ACT_topicalpdb_0040 | Wound Healing | Skin Penetrating | Not available in the current structured import | Unknown | Measurement of number of cups: Control:1.5 , Test:3; Radioactive assay, Measurement of number of cups; in vivo | 1267topicalpdb / linked |
| CTPDB_P036958_ACT_topicalpdb_0041 | Wound Healing | Skin Penetrating | Not available in the current structured import | Unknown | Measurement of number of cups: Control:4 , Test:9; Radioactive assay, Measurement of number of cups; in vivo | 1268topicalpdb / linked |
| CTPDB_P036958_ACT_topicalpdb_0042 | Wound Healing | Skin Penetrating | Not available in the current structured import | Unknown | Measurement of number of cups: Control:4.5 , Test:7.5; Radioactive assay, Measurement of number of cups; in vivo | 1269topicalpdb / linked |
| CTPDB_P036958_ACT_topicalpdb_0043 | Wound Healing | Skin Penetrating | Not available in the current structured import | Unknown | Measurement of number of cups: Control:7 , Test:15; Radioactive assay, Measurement of number of cups; in vivo | 1270topicalpdb / linked |
| CTPDB_P036958_ACT_topicalpdb_0044 | Wound Healing | Skin Penetrating | Not available in the current structured import | Unknown | Measurement of E2(Erection): Control:15 , Test:26; Radioactive assay, Measurement of E2(Erection); in vivo | 1271topicalpdb / linked |
| CTPDB_P036958_ACT_topicalpdb_0045 | Wound Healing | Skin Penetrating | Not available in the current structured import | Unknown | Measurement of E2(Erection): Control:4 , Test:11; Radioactive assay, Measurement of E2(Erection); in vivo | 1272topicalpdb / linked |
| CTPDB_P036958_ACT_topicalpdb_0046 | Wound Healing | Skin Penetrating | Not available in the current structured import | Unknown | Measurement of E2(Erection): Control:6 , Test:12; Radioactive assay, Measurement of E2(Erection); in vivo | 1273topicalpdb / linked |
| CTPDB_P036958_ACT_topicalpdb_0047 | Wound Healing | Skin Penetrating | Not available in the current structured import | Unknown | Measurement of E2(Erection): Control:11 , Test:24; Radioactive assay, Measurement of E2(Erection); in vivo | 1274topicalpdb / linked |
| CTPDB_P036958_ACT_topicalpdb_0048 | Wound Healing | Skin Penetrating | Not available in the current structured import | Unknown | Measurement of latency of first cup: Control:44 minutes , Test:38 minutes; Radioactive assay, Measurement of latency of first cup; in vivo | 1275topicalpdb / linked |
| CTPDB_P036958_ACT_topicalpdb_0049 | Wound Healing | Skin Penetrating | Not available in the current structured import | Unknown | Measurement of latency of first cup: Control:25.5 minutes , Test:19 minutes; Radioactive assay, Measurement of latency of first cup; in vivo | 1276topicalpdb / linked |
| CTPDB_P036958_ACT_topicalpdb_0050 | Wound Healing | Skin Penetrating | Not available in the current structured import | Unknown | Measurement of latency of first cup: Control:39 minutes , Test:32 minutes; Radioactive assay, Measurement of latency of first cup; in vivo | 1277topicalpdb / linked |
| CTPDB_P036958_ACT_topicalpdb_0051 | Wound Healing | Skin Penetrating | Not available in the current structured import | Unknown | Measurement of latency of first cup: Control:23 minutes , Test:15 minutes; Radioactive assay, Measurement of latency of first cup; in vivo | 1278topicalpdb / linked |
| CTPDB_P036958_ACT_topicalpdb_0052 | Wound Healing | Skin Penetrating | Not available in the current structured import | Unknown | Measurement of latency of first E2(Erection): Control:29 minutes , Test:31 minutes; Radioactive assay, Measurement of latency of first E2(Erection); in vivo | 1279topicalpdb / linked |
| CTPDB_P036958_ACT_topicalpdb_0053 | Wound Healing | Skin Penetrating | Not available in the current structured import | Unknown | Measurement of latency of first E2(Erection): Control:32 minutes , Test:16 minutes; Radioactive assay, Measurement of latency of first E2(Erection); in vivo | 1280topicalpdb / linked |
| CTPDB_P036958_ACT_topicalpdb_0054 | Wound Healing | Skin Penetrating | Not available in the current structured import | Unknown | Measurement of latency of first E2(Erection): Control:9 minutes , Test:3 minutes; Radioactive assay, Measurement of latency of first E2(Erection); in vivo | 1281topicalpdb / linked |
| CTPDB_P036958_ACT_topicalpdb_0055 | Wound Healing | Skin Penetrating | Not available in the current structured import | Unknown | Measurement of latency of first E2(Erection): Control:3.5 minutes , Test:2 minutes; Radioactive assay, Measurement of latency of first E2(Erection); in vivo | 1282topicalpdb / linked |
| CTPDB_P036958_ACT_topicalpdb_0056 | Wound Healing | Skin Penetrating | Not available in the current structured import | Unknown | 0.6% of the applied material was found in the penile tissue; Labelled peptide was detected and quantified by measuring radioactivity in a gamma counter; in vivo | 1348topicalpdb / linked |
| CTPDB_P036958_ACT_topicalpdb_0057 | Wound Healing | Skin Penetrating | Not available in the current structured import | Unknown | 5% of the applied material was found in the penile tissue; Labelled peptide was detected and quantified by measuring radioactivity in a gamma counter; in vivo | 1349topicalpdb / linked |
| CTPDB_P036958_ACT_topicalpdb_0058 | Wound Healing | Skin Penetrating | Not available in the current structured import | Unknown | 2.5% of the applied material was found in the penile tissue; Labelled peptide was detected and quantified by measuring radioactivity in a gamma counter; in vivo | 1350topicalpdb / linked |
| CTPDB_P036958_ACT_topicalpdb_0059 | Wound Healing | Skin Penetrating | Not available in the current structured import | Unknown | 1.25% of the applied material was found in the penile tissue; Labelled peptide was detected and quantified by measuring radioactivity in a gamma counter; in vivo | 1351topicalpdb / linked |
| CTPDB_P036958_ACT_topicalpdb_0060 | Wound Healing | Skin Penetrating | Not available in the current structured import | Unknown | Approximately 0.6% incorporation per 10 ml blood as a percentage of the total radioactivity applied; Radiolabelling assay is used to determine incorporation per 10 ml blood as a percentage of the total radioactivity applied using gamma counter.; in vivo | 1352topicalpdb / linked |
| CTPDB_P036958_ACT_topicalpdb_0061 | Wound Healing | Skin Penetrating | Not available in the current structured import | Unknown | Approximately 0.55% incorporation per 10 ml blood as a percentage of the total radioactivity applied; Radiolabelling assay is used to determine incorporation per 10 ml blood as a percentage of the total radioactivity applied using gamma counter.; in vivo | 1353topicalpdb / linked |
| CTPDB_P036958_ACT_topicalpdb_0062 | Wound Healing | Skin Penetrating | Not available in the current structured import | Unknown | Approximately 0.4% incorporation per 10 ml blood as a percentage of the total radioactivity applied; Radiolabelling assay is used to determine incorporation per 10 ml blood as a percentage of the total radioactivity applied using gamma counter.; in vivo | 1354topicalpdb / linked |
| CTPDB_P036958_ACT_topicalpdb_0063 | Wound Healing | Skin Penetrating | Not available in the current structured import | Unknown | Osmolarity measurements: t=0 min., VIP/Buffer=330/314.5mOsm/l; t=16 min., VIP/Buffer=315/313.5mOsm/l; Tear film osmolarity; in vivo | 1425topicalpdb / linked |
| CTPDB_P036958_ACT_topicalpdb_0064 | Wound Healing | Skin Penetrating | Not available in the current structured import | Unknown | Osmolarity measurements: t=0 min., VIP/Buffer=320/318mOsm/l; t=6 min., VIP/Buffer=303.5/310mOsm/l; t=16 min., VIP/Buffer=310/314mOsm/l; Tear film osmolarity; in vivo | 1426topicalpdb / linked |
| CTPDB_P036958_ACT_topicalpdb_0065 | Wound Healing | Skin Penetrating | Not available in the current structured import | Unknown | Osmolarity measurements: t=0 min., VIP/Buffer=315/320mOsm/l; t=6 min., VIP/Buffer=301/314mOsm/l; t=16 min., VIP/Buffer=308/313mOsm/l; Volume measurement: VIP/Buffer= 17µl/7µl; Osmolarity and tear volume measurements; in vivo | 1427topicalpdb / linked |
Provenance
HSDAVFTDNYTRLRKQMAVKKYLNSILN
HSDAVFTDNYTRLRKQMAVKKYLNSILN
HSDAVFTDNYTRLRKQMAVKKYLNSILN
HSDAVFTDNYTRLRKQMAVKKYLNSILN
HSDAVFTDNYTRLRKQMAVKKYLNSILN
HSDAVFTDNYTRLRKQMAVKKYLNSILN
HSDAVFTDNYTRLRKQMAVKKYLNSILN
HSDAVFTDNYTRLRKQMAVKKYLNSILN
HSDAVFTDNYTRLRKQMAVKKYLNSILN
HSDAVFTDNYTRLRKQMAVKKYLNSILN
HSDAVFTDNYTRLRKQMAVKKYLNSILN
HSDAVFTDNYTRLRKQMAVKKYLNSILN
HSDAVFTDNYTRLRKQMAVKKYLNSILN
HSDAVFTDNYTRLRKQMAVKKYLNSILN
HSDAVFTDNYTRLRKQMAVKKYLNSILN
HSDAVFTDNYTRLRKQMAVKKYLNSILN
HSDAVFTDNYTRLRKQMAVKKYLNSILN
HSDAVFTDNYTRLRKQMAVKKYLNSILN
HSDAVFTDNYTRLR KQMAVKKYLNSILN
HSDAVFTDNYTRLR KQMAVKKYLNSILN
HSDAVFTDNYTRLR KQMAVKKYLNSILN
HSDAVFTDNYTRLR KQMAVKKYLNSILN
HSDAVFTDNYTRLR KQMAVKKYLNSILN
HSDAVFTDNYTRLR KQMAVKKYLNSILN
HSDAVFTDNYTRLR KQMAVKKYLNSILN
HSDAVFTDNYTRLR KQMAVKKYLNSILN
HSDAVFTDNYTRLR KQMAVKKYLNSILN
HSDAVFTDNYTRLR KQMAVKKYLNSILN
HSDAVFTDNYTRLR KQMAVKKYLNSILN
HSDAVFTDNYTRLR KQMAVKKYLNSILN
HSDAVFTDNYTRLR KQMAVKKYLNSILN
HSDAVFTDNYTRLR KQMAVKKYLNSILN
HSDAVFTDNYTRLR KQMAVKKYLNSILN
HSDAVFTDNYTRLR KQMAVKKYLNSILN
HSDAVFTDNYTRLR KQMAVKKYLNSILN
HSDAVFTDNYTRLR KQMAVKKYLNSILN
HSDAVFTDNYTRLR KQMAVKKYLNSILN
HSDAVFTDNYTRLR KQMAVKKYLNSILN
HSDAVFTDNYTRLR KQMAVKKYLNSILN
HSDAVFTDNYTRLR KQMAVKKYLNSILN
HSDAVFTDNYTRLR KQMAVKKYLNSILN
HSDAVFTDNYTRLR KQMAVKKYLNSILN
HSDAVFTDNYTRLR KQMAVKKYLNSILN
HSDAVFTDNYTRLR KQMAVKKYLNSILN
Citation trail
{"reference": "J Neuroimmunol. 2008 Aug 30;200(1-2):11-6", "title": "Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites.", "author": "El Karim IA, Linden GJ, Orr DF, Lundy FT.2008"}
-
-
El Karim IA, Linden GJ, Orr DF, Lundy FT
-
{"doi": "10.13345/j.cjb.170506.", "reference": "[J].生物工程学报,2018,34(06):1002-1011.DOI:10.13345/j.cjb.170506.", "author": "乔想金,李文新,白丽娟:Xiangjin Qiao,Wnxin Li,Lijun Bai,Wei Hu,Huai Nan", "title": "抗菌肽VIP在毕赤酵母中的高效表达及鉴定; Expression and identification of an antimicrobial peptide VlP in Pichiapastoris"}
-
[{"text": "drugbank.com", "url": "https://go.drugbank.com/drugs/DB06260", "markdown": "[drugbank.com](https://go.drugbank.com/drugs/DB06260)"}, {"text": "mims.co.uk", "url": "https://www.mims.co.uk/aviptadil-phentolamine-launched-combination-treatment-erectile-dysfunction/mens-health/article/1370338", "markdown": "[mims.co.uk](https://www.mims.co.uk/aviptadil-phentolamine-launched-combination-treatment-erectile-dysfunction/mens-health/article/1370338)"}, {"text": "nice.org.uk", "url": "https://b
-
-
-
Audit surface
Integrated record last updated: 2026-04-15T00:59:11.491115+00:00
Modification summary
No structured modification annotations are available for this record.
{
"toxicity": [
{
"unit": "µg/ml",
"value": "100",
"source_db": "dbaasp",
"assay_method": "10% Cell death",
"toxicity_type": "Cytotoxic",
"target_cellline": "Human pulp fibroblasts"
}
]
}[
{
"source_db": "apd",
"organism_name": "Unknown"
},
{
"source_db": "b3pdb",
"organism_name": "Unknown"
},
{
"source_db": "camp",
"organism_name": "Unknown"
},
{
"source_db": "dbaasp",
"organism_name": "Unknown"
},
{
"source_db": "dramp",
"organism_name": "Unknown"
},
{
"source_db": "parapep",
"organism_name": "Unknown"
},
{
"source_db": "peptherdia",
"organism_name": "Unknown"
},
{
"source_db": "satpdb",
"organism_name": "Unknown"
},
{
"source_db": "topicalpdb",
"organism_name": "Unknown"
}
]{
"pdb_id": [
"2RRH",
"Not found"
],
"source_db": "dramp"
}[
{
"status": "Therapeutic (orphan)",
"drug_name": "Aviptadil",
"source_db": "peptherdia",
"indication": "Erectile dysfunction (in combination with phentolamine)",
"approval_year": 2000,
"approval_agency": "MedSafe",
"administration_route": "Intracavernous injection"
}
]{
"status": "Therapeutic (orphan)",
"drug_name": "Aviptadil",
"source_db": "peptherdia",
"indication": "Erectile dysfunction (in combination with phentolamine)",
"approval_year": 2000,
"approval_agency": "MedSafe",
"administration_route": "Intracavernous injection"
}